Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Healthcare Medical Devices
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018

GlobeNewswire October 25, 2018

OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ET

GlobeNewswire October 23, 2018

OptimizeRx Acquires CareSpeak Communications

GlobeNewswire October 17, 2018

OptimizeRx Invited to Co-Host Plenary Session at Digital Pharma East on October 17, 2018

GlobeNewswire October 10, 2018

OptimizeRx Partners with Medicom Health to Bring Automated Medication Savings Directly to Patients at Hospitals Nationwide

GlobeNewswire September 27, 2018

OptimizeRx Launches ROI Guarantee to Pharmaceutical Manufacturers

GlobeNewswire September 12, 2018

OptimizeRx to Participate at Lake Street Capital Markets Best Ideas Growth Conference on September 13, 2018

GlobeNewswire August 29, 2018

OptimizeRx Reports Second Quarter 2018 Results; Net Revenue Up 78% to Record $5.1 Million, Driving $0.02 EPS

GlobeNewswire August 7, 2018

OptimizeRx Sets Second Quarter 2018 Conference Call for Tuesday, August 7, 2018 at 4:30 p.m. ET

GlobeNewswire July 17, 2018

OptimizeRx Uplists to the Nasdaq Capital Market

GlobeNewswire June 19, 2018

OptimizeRx Goes Global via Strategic Partnership with London-based Patient Connect; Expands Digital Messages to International Point-of-Care

GlobeNewswire May 14, 2018

OptimizeRx Reverse Splits Stock 1-for-3 in Preparation for Nasdaq Listing

GlobeNewswire May 14, 2018

OptimizeRx to Participate at B. Riley FBR’s 19th Annual Institutional Investor Conference on May 23-24, 2018

GlobeNewswire May 9, 2018

OptimizeRx Completes $9 Million Private Placement

GlobeNewswire May 8, 2018

OptimizeRx Announces $9 Million Private Placement

GlobeNewswire May 2, 2018

OptimizeRx Reports First Quarter 2018 Results; Q1 Net Revenue Up 91% to Record $4.1 Million

GlobeNewswire May 2, 2018

OptimizeRx Sets First Quarter 2018 Conference Call for Wednesday, May 2, 2018 at 4:30 p.m. ET

GlobeNewswire April 18, 2018

OptimizeRx Appoints Patrick Spangler and Bryan Archambault to Board of Directors

GlobeNewswire March 27, 2018

OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

PR Newswire March 8, 2018

Developments in the Healthcare Analytics Market

PR Newswire March 7, 2018